AQS:CA Aequus Pharmaceuticals Inc.Stock Price & Overview
$0.04
TSXV | $CAD | Market Close
Charts
Quant Ranking
Analysis
News
Latest Headlines

People Also Follow
Company Profile
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.